Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Frequently Asked Questions
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • In the News

Navidea Biopharmaceuticals Wins Dismissal of Platinum Litigation

Oct 31, 2018

Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American

Oct 30, 2018

Navidea Biopharmaceuticals to Present Data on the Manocept Platform at 2018 ACR Annual Meeting

Oct 11, 2018

Navidea Biopharmaceuticals to Present at the 2018 BIO Investor Forum

Oct 8, 2018

Navidea Biopharmaceuticals Announces Acceptance into the National Institutes of Health Commercialization Accelerator Program

Sep 17, 2018

Navidea Biopharmaceuticals Announces Closing of a $3 Million Private Placement

Sep 17, 2018

Navidea Biopharmaceuticals Announces Results of the Annual Shareholder Meeting

Aug 17, 2018

Navidea Biopharmaceuticals Announces Details of 2018 Annual General Meeting

Aug 16, 2018

Navidea Biopharmaceuticals Receives Noncompliance Notice From NYSE American

Aug 15, 2018

Navidea Biopharmaceuticals Reports Second Quarter 2018 Financial Results

Aug 8, 2018
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...31
    © 2019 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap